MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Myoclonus in a Large Urban Center: 10 Year Experience

    K. Oh, M. Hamed, H. Sarva, D. Victor (New York, USA)

    Objective: To describe various forms of myoclonus in admitted patients in a 10-year period. Background: Myoclonus consists of brief, shock-like involuntary movements. It may occur…
  • 2022 International Congress

    Local Field Potential Recordings in Parkinson’s Disease at Home: A Case Series Report

    K. Martinez, V. Madrigal, N. Morelli, A. Singer (Aliso Viejo, USA)

    Objective: To report novel, real-world use of chronic local field potential (LFP) sensing in patients with Parkinson’s disease (PD) outside-of-clinic settings. Background: Recent advancements in…
  • 2022 International Congress

    Central oscillation in the basal ganglia during re-emergent tremor pause in Parkinson’s Disease

    M. Wilken, G. Bianchi, D. Andrés, M. Hallett, M. Merello (Buenos Aires, Argentina)

    Objective: To correlate central oscillation in the basal ganglia with EMG activity during re-emergent tremor pause. Background: According to the dimmer-switch model, basal ganglia act…
  • 2022 International Congress

    Cholinergic Nucleus 4 Degeneration and Cognitive Impairment in REM Sleep Behavior Disorder

    C. Tan, H. Nawaz, S. Lageman, B. Berman, N. Mukhopadhyay, M. Barrett (Richmond, USA)

    Objective: To determine if there is evidence of cholinergic basal forebrain degeneration, i.e., reduced cholinergic nucleus 4 (Ch4) volume on MRI, in patients with REM…
  • 2022 International Congress

    Phenotypical and treatment response heterogeneity in a cohort of normal pressure hydrocephalus patients

    A. Di Maio, G. Lazzeri, F. Arienti, F. Ruggiero, F. Mameli, A. Di Fonzo, G. Franco (Milan, Italy)

    Objective: To clinically characterize a cohort of patients with normal pressure hydrocephalus (NPH) to identify possible clinical and humoral biomarkers that can predict the response…
  • 2022 International Congress

    Low-dose lithium therapy associated with increased PBMC Nurr1 and SOD1 expression in Parkinson’s disease: a pilot study.

    T. Guttuso, JR., R. Shepherd, M. Tamano, M. Ramanathan, V. Frerichs, L. Frick (Williamsville, USA)

    Objective: To determine the effects of lithium therapy on blood-based biomarkers in Parkinson’s disease (PD). Background: Lithium has multiple neuroprotective actions and may account for…
  • 2022 International Congress

    Relation of affective disorders and quality of life in the chronic pain of disease Parkinson’s patients

    K. Stepanchenko, A. Jidkova (Kharkiv, Ukraine)

    Objective: To study affective disorders and their impact on the quality of life in patients with PD and chronic pain syndrome. Background: Mechanisms of the…
  • 2022 International Congress

    Clinical presentation of SNCA Duplication Parkinsonism in a Family Kindred

    K. Dent, M. Rochman, D. Kremens, J. Ratliff (Philadelphia, USA)

    Objective: To report phenotype variability in a family with SNCA duplication associated Parkinsonism. Background: Pathogenic variants in SNCA, the gene coding for α-synuclein, cause familial…
  • 2022 International Congress

    Awake versus Asleep Deep Brain Stimulation Lead Placement: Real-World Outcomes with Directional DBS Systems

    J. Vesper, G. Deuschl, L. Chen, R. Jain (Düsseldorf, Germany)

    Objective: In this report, real-world outcomes derived from Parkinson's disease (PD) patients using Deep Brain Stimulation (DBS) Systems who were implanted either awake or asleep…
  • 2022 International Congress

    Geographic and Financial Trends in the Utilization of Deep Brain Stimulation in the Medicare Population from 2013-2019

    T. Gossard, A. Khurana, J. Chan, S. Aslam (Phoenix, USA)

    Objective: To evaluate the utilization of deep brain stimulation within the Medicare population across different regions and states in the United States Background: Deep brain…
  • « Previous Page
  • 1
  • …
  • 593
  • 594
  • 595
  • 596
  • 597
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley